These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2598404)

  • 1. In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell lines.
    Xu MJ; Alberts DS; Liu R; Leibovitz A; Liu Y
    Cancer Chemother Pharmacol; 1989; 25(2):89-94. PubMed ID: 2598404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer.
    Lidor YJ; Shpall EJ; Peters WP; Bast RC
    Int J Cancer; 1991 Nov; 49(5):704-10. PubMed ID: 1937956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of new drugs and combinations in gynecologic tumors and cancer cell lines with the ATP-cell viability assay.
    Untch M; Sevin BU
    Contrib Gynecol Obstet; 1994; 19():145-55. PubMed ID: 7995046
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients.
    Holloway RW; Mehta RS; Finkler NJ; Li KT; McLaren CE; Parker RJ; Fruehauf JP
    Gynecol Oncol; 2002 Oct; 87(1):8-16. PubMed ID: 12468336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin.
    Kozar K; Kaminski R; Legat M; Kopec M; Nowis D; Skierski JS; Koronkiewicz M; Jakóbisiak M; Golab J
    Int J Oncol; 2004 May; 24(5):1149-57. PubMed ID: 15067336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells.
    Bonavida B; Tsuchitani T; Zighelboim J; Berek JS
    Gynecol Oncol; 1990 Sep; 38(3):333-9. PubMed ID: 2227544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines.
    Kaufmann SH; Peereboom D; Buckwalter CA; Svingen PA; Grochow LB; Donehower RC; Rowinsky EK
    J Natl Cancer Inst; 1996 Jun; 88(11):734-41. PubMed ID: 8637027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
    Ohie S; Udagawa Y; Kozu A; Komuro Y; Aoki D; Nozawa S; Moossa AR; Hoffman RM
    Anticancer Res; 2000; 20(3B):2049-54. PubMed ID: 10928150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells.
    Noseda A; Berens ME; White JG; Modest EJ
    Cancer Res; 1988 Apr; 48(7):1788-91. PubMed ID: 3349458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination treatment with trabectedin and irinotecan or topotecan has synergistic effects against ovarian clear cell carcinoma cells.
    Kawano M; Mabuchi S; Kishimoto T; Hisamatsu T; Matsumoto Y; Sasano T; Takahashi R; Sawada K; Takahashi K; Takahashi T; Hamasaki T; Kimura T
    Int J Gynecol Cancer; 2014 Jun; 24(5):829-37. PubMed ID: 24844217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis.
    Levin L; Simon R; Hryniuk W
    J Natl Cancer Inst; 1993 Nov; 85(21):1732-42. PubMed ID: 8411257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay.
    Saito T; Berens ME; Welander CE
    Cancer Chemother Pharmacol; 1987; 19(3):233-9. PubMed ID: 3107848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The growth-inhibitory effect of 4-hydroperoxycyclophosphamide against human non-small cell lung carcinoma is enhanced by low-dose difluoromethylornithine.
    Tsai DC; Luk GD
    Cancer Chemother Pharmacol; 1988; 22(1):36-40. PubMed ID: 2840221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.
    Sharp SY; Rowlands MG; Jarman M; Kelland LR
    Br J Cancer; 1994 Sep; 70(3):409-14. PubMed ID: 8080723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance.
    Martirosyan A; Clendening JW; Goard CA; Penn LZ
    BMC Cancer; 2010 Mar; 10():103. PubMed ID: 20298590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for gynecologic malignancies at Siriraj Hospital, Bangkok.
    Senapad S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):656-9. PubMed ID: 3939044
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitizing effect of an antiestrogen, toremifene, on ovarian cancer.
    Mäenpää J; Sipilä P; Kangas L; Karnani P; Grönroos M
    Gynecol Oncol; 1992 Sep; 46(3):292-7. PubMed ID: 1388131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
    Mäenpää J; Kangas L; Grönroos M
    Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.